Cabaletta Bio Stock Net Asset
| CABA Stock | USD 4.91 0.06 1.24% |
Cabaletta Bio fundamentals help investors to digest information that contributes to Cabaletta Bio's financial success or failures. It also enables traders to predict the movement of Cabaletta Stock. The fundamental analysis module provides a way to measure Cabaletta Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cabaletta Bio stock.
Cabaletta | Net Asset |
Cabaletta Bio Company Net Asset Analysis
Cabaletta Bio's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Cabaletta Bio Net Asset | 253.65 M |
Most of Cabaletta Bio's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cabaletta Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cabaletta Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Cabaletta Bio is extremely important. It helps to project a fair market value of Cabaletta Stock properly, considering its historical fundamentals such as Net Asset. Since Cabaletta Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cabaletta Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cabaletta Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Cabaletta Total Assets
Total Assets |
|
Based on the recorded statements, Cabaletta Bio has a Net Asset of 253.65 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Cabaletta Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cabaletta Bio's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cabaletta Bio could also be used in its relative valuation, which is a method of valuing Cabaletta Bio by comparing valuation metrics of similar companies.Cabaletta Bio is currently under evaluation in net asset category among its peers.
Cabaletta Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cabaletta Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cabaletta Bio's managers, analysts, and investors.Environmental | Governance | Social |
Cabaletta Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Cabaletta Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cabaletta Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cabaletta Bio's value.| Shares | Sofinnova Ventures | 2024-06-30 | 1.2 M | Stempoint Capital Lp | 2024-06-30 | 1.2 M | Commodore Capital Lp | 2024-06-30 | 1.1 M | Geode Capital Management, Llc | 2024-06-30 | 970.6 K | Jpmorgan Chase & Co | 2024-06-30 | 956.7 K | Millennium Management Llc | 2024-06-30 | 698.3 K | Victory Capital Management Inc. | 2024-06-30 | 634.2 K | Perceptive Advisors Llc | 2024-06-30 | 585 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 582.3 K | Jennison Associates Llc | 2024-06-30 | 5.5 M | Blackrock Inc | 2024-06-30 | 4.8 M |
Cabaletta Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.31 | ||||
| Current Valuation | 43.78 M | ||||
| Shares Outstanding | 48.85 M | ||||
| Shares Owned By Insiders | 3.09 % | ||||
| Shares Owned By Institutions | 96.91 % | ||||
| Number Of Shares Shorted | 5.32 M | ||||
| Price To Earning | (3.33) X | ||||
| Price To Book | 1.20 X | ||||
| EBITDA | (73.23 M) | ||||
| Net Income | (67.67 M) | ||||
| Cash And Equivalents | 96.81 M | ||||
| Cash Per Share | 3.34 X | ||||
| Total Debt | 5.02 M | ||||
| Debt To Equity | (3.76) % | ||||
| Current Ratio | 15.22 X | ||||
| Book Value Per Share | 4.13 X | ||||
| Cash Flow From Operations | (53.55 M) | ||||
| Short Ratio | 5.41 X | ||||
| Earnings Per Share | (1.91) X | ||||
| Target Price | 22.9 | ||||
| Number Of Employees | 136 | ||||
| Beta | 2.39 | ||||
| Market Capitalization | 239.6 M | ||||
| Total Asset | 253.65 M | ||||
| Retained Earnings | (233.24 M) | ||||
| Working Capital | 228.5 M | ||||
| Current Asset | 30.42 M | ||||
| Current Liabilities | 843.74 K | ||||
| Net Asset | 253.65 M |
About Cabaletta Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cabaletta Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cabaletta Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cabaletta Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| F | Ford Motor | |
| CRM | Salesforce |
Check out Cabaletta Bio Piotroski F Score and Cabaletta Bio Altman Z Score analysis. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Return On Assets (0.31) | Return On Equity (0.48) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.